BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 25.07.2017

M4E(R2): The Common Technical Document-Efficacy; International Council for Harmonisation; Guidance for Industry; Availability

The Food and Drug Administration (FDA or Agency) is announcing the availability of a guidance entitled "M4E(R2): The CTD--Efficacy." The guidance was prepared under the auspices of the International Council for Harmonisation (ICH), formerly the International Conference on Harmonisation. The guidance revises the ICH guidance "M4E: The CTD--Efficacy" (M4E guidance). The revised guidance standardizes the presentation of benefit-risk information in regulatory submissions, providing greater specificity on the format and structure of benefit- risk information. This revision is intended to facilitate communication among regulators and industry.

Source: Federal Register — Food and Drug AdministrationOpen original release →